1Department of Antibiotic Resistance and Infection Prevention, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213 Oslo, NO Norway.
2European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden.
Antimicrob Resist Infect Control. 2018 Nov 29;7:146. doi: 10.1186/s13756-018-0429-7. eCollection 2018.
We aimed to estimate the prevalence of faecal carriage of extended-spectrum cephalosporin (ESC) resistant and (ESCr-EK) and vancomycin resistant enterococci (VRE) in patients upon hospital admission and identify factors associated with carriage to better target interventions and to guide empirical antibiotic treatment.
Between October 2014 and December 2016, we recruited patients admitted to a Norwegian university hospital. A rectal swab and questionnaire covering possible risk factors for colonisation were collected upon admission. Isolates were characterized by phenotypic methods. ESCr-EK isolates were subject to whole genome sequencing. We calculated prevalence and adjusted prevalence ratios (aPR) using binomial regression.
Of 747 patients, 45 (6.0%) were colonised with ESCr-EK none with VRE The ESCr-EK isolates in 41 patients were multidrug resistant; no isolates were non-suceptible to meropenem. Prevalence of ESCr-EK was higher among travellers to Asia (aPR = 6.6; 95%CI 3.6-12; < 0.001). No statistical significant difference in carriage was observed between departments, age or any other factors in the univariable analyses.
The observed prevalence of ESCr-EK colonisation upon admission was in the same range but lower than that reported in similar studies from Europe. Travel to Asia was a strong predictor for colonisation of ESCr-EK to be considered when administering empirical antimicrobial treatment. As less than one third of colonised patients had travelled to Asia, and no other factors investigated were found to be strongly associated with carriage, these findings underscore that healthcare personnel must apply standard infection control precautions for all patients.
我们旨在评估入院患者粪便中携带广谱头孢菌素(ESC)耐药和(ESCr-EK)和万古霉素耐药肠球菌(VRE)的流行率,并确定与携带相关的因素,以便更好地进行干预,并指导经验性抗生素治疗。
在 2014 年 10 月至 2016 年 12 月期间,我们招募了挪威一所大学医院的入院患者。入院时采集直肠拭子和一份涵盖定植可能危险因素的问卷。采用表型方法对分离株进行鉴定。对 ESCr-EK 分离株进行全基因组测序。我们使用二项式回归计算流行率和调整后的流行率比(aPR)。
在 747 名患者中,有 45 名(6.0%)定植了 ESCr-EK,无一例定植 VRE。41 名患者的 ESCr-EK 分离株为多药耐药;无分离株对美罗培南不敏感。亚洲旅行者的 ESCr-EK 携带率较高(aPR=6.6;95%CI 3.6-12; < 0.001)。在单变量分析中,各科室、年龄或其他任何因素之间均未观察到携带率的统计学显著差异。
入院时观察到的 ESCr-EK 定植流行率与类似的欧洲研究报告的流行率相当,但略低。亚洲旅行是 ESCr-EK 定植的一个强有力的预测因素,在进行经验性抗菌治疗时应予以考虑。由于不到三分之一的定植患者曾前往亚洲,且未发现其他因素与携带密切相关,这些发现强调医护人员必须对所有患者采取标准的感染控制预防措施。